Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharmacol Exp Ther ; 294(2): 728-34, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10900254

ABSTRACT

The aim of the present study was to investigate whether functional changes at CA3-CA1 synapses in the hippocampus could underlie learning and memory deficits produced in rat offspring by a prenatal exposure model simulating the carbon monoxide (CO) exposure observed in human cigarette smokers. Electrophysiological endpoints, including long-term potentiation, were examined in 15- to 30-day-old male rats whose mothers were exposed, from day 0 to day 20 of gestation, to 150 ppm of CO resulting in blood levels of carboxyhemoglobin comparable to those found in human cigarette smokers. Evoked field excitatory postsynaptic potentials were measured in the stratum radiatum in hippocampal slices. Results show that before tetanus, input/output functions, presynaptic volley, and paired-pulse facilitation were not affected in CO-exposed offspring, indicating that basal synaptic excitability and terminal Ca(2+) influx were not influenced by prenatal exposure to this gas. Conversely, evoked field excitatory postsynaptic potentials potentiation in response to tetanization was reduced by about 23% and decayed rapidly to baseline values in slices from CO-exposed animals. No changes between and within groups were observed in paired-pulse facilitation after tetanus. The selective impairment of long-term potentiation expression exhibited by CO-exposed rats was paralleled by a significant decrease in heme-oxygenase 2 and neuronal nitric-oxide synthase in the hippocampus. No changes in either enzymatic activity were found in frontal cortex and cerebellum. These electrophysiological and biochemical alterations might account for cognitive deficits previously observed in rats exposed prenatally to CO. Our findings could have clinical implications for the offspring of mothers who smoke during pregnancy.


Subject(s)
Carbon Monoxide/toxicity , Long-Term Potentiation/drug effects , Prenatal Exposure Delayed Effects , Pyramidal Cells/drug effects , Animals , Carboxyhemoglobin/metabolism , Cerebellum/drug effects , Cerebellum/enzymology , Excitatory Postsynaptic Potentials/drug effects , Female , Frontal Lobe/drug effects , Frontal Lobe/enzymology , Heme Oxygenase (Decyclizing)/metabolism , Male , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type I , Pregnancy , Pyramidal Cells/enzymology , Pyramidal Cells/physiology , Rats , Rats, Wistar , Synaptic Transmission/drug effects
2.
Proc Natl Acad Sci U S A ; 97(15): 8653-7, 2000 Jul 18.
Article in English | MEDLINE | ID: mdl-10890901

ABSTRACT

Members of the Src family of nonreceptor protein tyrosine kinases (PTKs) have been implicated in the regulation of cellular excitability and synaptic plasticity. We have investigated the role of these PTKs in in vitro models of epileptiform activity. Spontaneous epileptiform discharges were induced in vitro in the CA3 region of rat hippocampal slices by superfusion with the potassium channel blocker 4-aminopyridine in Mg(2+)-free medium. In hippocampal slices treated in this fashion, Src kinase activity was increased and the frequency of epileptiform discharges could be greatly reduced by inhibitor of the Src family of PTKs, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2), but not by the inactive structural analog 4-amino-7-phenylpyrazol[3,4-d]pyrimidine (PP3). 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine also reduced epileptiform activity induced by either 4-aminopyridine or Mg(2+)-free medium alone. These observations demonstrate a role for Src family PTKs in the pathophysiology of epilepsy and suggest potential therapeutic targets for antiepileptic therapy.


Subject(s)
Epilepsy/physiopathology , Hippocampus/physiology , src-Family Kinases/physiology , 2-Amino-5-phosphonovalerate/pharmacology , 4-Aminopyridine/pharmacology , Animals , Electrophysiology , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Hippocampus/drug effects , In Vitro Techniques , Magnesium/pharmacology , Male , Potassium Channel Blockers , Pyrimidines/pharmacology , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , src-Family Kinases/antagonists & inhibitors
3.
Eur J Pharmacol ; 380(2-3): 109-16, 1999 Sep 10.
Article in English | MEDLINE | ID: mdl-10513569

ABSTRACT

Gamma-Hydroxybutyrate (GHB) has been shown to mimic different central actions of ethanol, to suppress alcohol withdrawal syndrome, and to reduce alcohol consumption both in rats and in humans. The aim of the present study was to determine if GHB shared with alcohol the ability to inhibit glutamate action at both NMDA and AMPA/kainate receptors. The NMDA or the AMPA/kainate receptors-mediated postsynaptic potentials were evoked in CA1 pyramidal neurons by stimulation of Schaffer-collateral commissural fibers in the presence of CGP 35348, bicuculline to block the GABA(B) and GABA(A) receptors, and 10 microM 6,7-dinitroquinoxaline-2,3-dione (DNQX) or 30 microM DL-2-amino-5-phosphonovalerate (d-APV) to block AMPA/kainate or NMDA receptors, respectively. GHB (600 microM) produced a depression of both NMDA and AMPA/kainate receptors-mediated excitatory postsynaptic potentials with recovery on washout. The GHB receptors antagonist, NCS-382, at the concentration of 500 microM had no effect per se on these responses but prevented the depressant effect of GHB (600 microM) on the NMDA and AMPA/kainate-mediated responses. In the paired-pulse experiments, GHB (600 microM) depressed the amplitude of the first and the second evoked AMPA/kainate excitatory postsynaptic potentials, and significantly increased the paired-pulse facilitation (PPF). These results suggest that GHB inhibits excitatory synaptic transmission at Schaffer-collateral commissural-pyramidal neurons synapses by decreasing the probability of release of glutamate.


Subject(s)
Adjuvants, Anesthesia/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Hippocampus/drug effects , Sodium Oxybate/pharmacology , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Benzocycloheptenes/pharmacology , Bicuculline/pharmacology , Dose-Response Relationship, Drug , Excitatory Amino Acid Antagonists/pharmacology , GABA Antagonists/pharmacology , Hippocampus/cytology , Hippocampus/physiology , In Vitro Techniques , Male , Membrane Potentials/drug effects , Neurons/drug effects , Neurons/physiology , Organophosphorus Compounds/pharmacology , Quinoxalines/pharmacology , Rats , Rats, Wistar , Receptors, AMPA/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...